2008 Sessions Downloads

CoSMoS 2008 Presentations

July 28- July 30, 2008
San Jose, CA

Downloads  (PDF Files unless noted )

Session 1 – Perspectives: Future Demands in Analytical Practice
Session Chair: Michael P. Balogh, Waters Corporation

The Anti-intellectual Effects of Intellectual Property
— Chris Lipinski, Scientific Advisor, Melior Discovery

Accurate Mass Measurement of Small Molecules – The Past, The Present and The Exciting Future
— Anthony Bristow, AstraZeneca

Session 2 – Fundamental Topics in Structure Elucidation
Session Chair: David Stranz, Sierra Analytics

The Role of Structure Elucidation in Building and Evaluating Libraries of Bioactive Compounds from Marine Organisms
— Phil Crews

Using GC-MS, LC-MS and FT-ICR-MS Data for Structure Elucidation of Small Molecules
— Tobias Kind, UC Davis Genome Center-Metabolomics

Big Signals without Big Magnets: An Early Assessment of the Utility of Dynamic Nuclear Polarisation for Routine 13C and 15N NMR Spectroscopy
— Adrian L. Davis, Pfizer Global Research and Development

Session 3 – Structure Elucidation-Applications and Problem Solving
Session Chair: David Stranz, Sierra Analytics

Efficient Multidisciplinary NMR and MS Structure Elucidation in the Age of High Sensitivity NMR
— David J. Detlefsen Ph.D., Novatia LLC

Higher Throughput Profiling of Drug Metabolites in Drug Discovery using High-Resolution Mass Spectrometry and Data Mining Techniques (Presentation not available)
— Mingshe Zhu Ph.D., Bristol-Myer Squibb Research and Development

FDA Forensic Investigations using Mass Spectrometry
— Bryan M. Gamble Ph.D., U.S. Food and Drug Administration, Forensic Chemistry Center

Session 4 – The Science of Practical Chromatography

Session Chair: Nelu Grinberg, Boehringer-Ingelheim Pharmaceuticals, Inc.

The Need for Resolution (sometimes) in Bioanalytical LC-MS/MS

— Michael Donegan,Bristol-Myers Squibb

Explaining Separation Phenomenon Through the use of Molecular Modeling and NMR
— Roy Helmy, Merck & Co

Mechanistix Aspects of Chiral Discrimination on Polysacharides Phases
— Nelu Grinberg, Boehringer-Ingelheim Pharmaceuticals, Inc..

Session 5 -Atmospheric Ionization Technologies: Where are we now?

Justin Wiseman, Prosolia (Presentaion not available)
Chuck McEwen, DuPont Corporate Center for Analytical Science
Yeping Zhao, Roche

Excellence In Science Award Winner
Yeping Zhao, Roche